The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© Thomson Reuters 2020.Shortage of patients for clinical trials hampers Japan's search for COVID-19 treatments
By Rocky Swift TOKYO©2024 GPlusMedia Inc.
20 Comments
Login to comment
Penfold
Normally 5-7 years for testing vaccines. Let’s not panic and rush into anything here
gokai_wo_maneku
The "shortage of patients" is a great thing. Don't complain.
Yubaru
Personally speaking, no one in their right mind is going to want to volunteer for testing a vaccination here, the risks far outweigh the benefits, and in my opinion, these companies will not do enough for people who WILL become ill from the vaccination itself and possibly die, or worse!
kurisupisu
Japan always seems to have groundbreaking research but treatments stemming from them never seem to. be widely available or plain overpriced-why?
virusrex
The complaint is not about hoping for more patients, but to preemptively explain why proper trials cannot be expected from studies inside the country. Eventually people will come to complain that Japanese companies could not even put a single vaccine on the market at the same time as other countries or why they had to run their trials on Brazil instead of Japan, this is the reason.
When health care professionals that have dedicated their lives to cure and protect people and have recognized careers say the opposite of what you think, personally speaking, I would say more people are going to listen to them instead of you, specially when they have scientific data to support their conclusions.
tokyo_joe
Pretty hard to find people with Covid when you do no testing. If they started mass testings like other countries I'm sure they'd find lots of potential vaccine guinea pigs.
half-hearted jumper
Yup. Was going to say the exact same thing. Test less than 1% of the population - expect to have really low numbers (almost a Trumpian thing).
Blitzwing
Hahaha, sure
Goodlucktoyou
Just a suggestion, why test in Japan? when Brazil is a virus breeding ground and many poor people there would jump at the opportunity to earn ¥50000 for a clinical trial.
Eppee
I believe testing a vaccine should be about getting people who do not have the virus but are at risk, vaccinating half and compare the outcome though.
kazetsukai
This simple report just gave us a much needed and better perspective on the pandemic.
It "appears" that there are "fewer" people being hospitalized after contracting the virus, even with fewer testing in Japan compared to those that have extensive testing. It also indicates that many people in Japan are weary of being tested upon using a vaccine even if there is a pandemic. Which seem to indicate that the fear of the vaccine itself is greater than the virus itself.
It also indicates that while "money" seem to buy a lot of things, including people, that may not be the case here. Whether it is the amount of payment or the "reputation" of the reliability trust placed upon the drug company, when left to individual"choice", the Japanese are rather thoughful and independent. That is unless the authority (what ever that may be) that they choose to trust recommends or prescribes an action to take.
virusrex
The most important reason because ethical committees put a lot of red tape on doing this. A lot of times compensation end up being prohibited (because of bias and ethical concerns) and a lot of preliminary studies and commitments become requisites (for example is necessary to prove the immunity and related medical factors are equivalent between the studied population and the intended target, and a certain amount of vaccine has to be provided at a competitive cost for the population tested if it turns out to be effective and safe, to avoid accusations that they were just used without receiving the benefits of the research, etc.)
So it increases cost, reduces the control that the researchers have about the test conditions and requires several extra steps to be approved in at least 2 countries. That is why it is never the first option.
@kazetsukai
Nothing in this report indicates that. Simple lack of infections is enough to explain low number of hospitalizations.
No, that is mistaken, the researchers have no reason to vaccinate people that are extremely unlikely to get infected, there is no reports of people refusing to become volunteers, just that there is not value on even recruiting those volunteers in Japan. Nothing indicates that Japanese people have any special fear of vaccination.
That is false, clinical trials have extremely sever ethical standards to fulfill, and that includes compensation for the volunteers. For a vaccine candidate with proper studies the compensation is usually nothing that would convince anybody of volunteering if they did not have that intention from the beginning.
You are just assuming a lot of things that are not written anywhere and are likely false.
Luddite
If there was more than a tiny number of the population being tested then more people with the virus would be identified. Just a thought.
Aly Rustom
Agree with the 3 comments above
Christopher Glen
Japan’s success? Japan has just been very lucky. The doomsday scenario many predicted has yet to pass, but...the virus is likely far more prevalent than is being let on.
Is that cause for panic? Not necessarily
Jtsnose
There are still many new patients in California, USA and other Western states. . . . some who may be of Japanese background. Perhaps these patients can be asked if they would like try it.
drlucifer
Shouldn't it be
Due to the decreasing number of PCR testing.
Yubaru
You do realize the article is about Japanese pharma and not the medical health professionals that you are talking about here!
I guess in your rush to respond, you didnt read the article did you? Wait, why do I even ask this question when your response here already gives me the answer!
virusrex
Who do you think are developing and testing vaccines and drugs? only "pharma"? why do you think health ministry officials and doctors from universities are giving their opinion in the article?
Because doctors and other health professionals are deeply involved in the whole process, from those in a tiny clinic on the countryside to those working in Geneva for the WHO. They actively design the studies, are part of the ethical committees giving permision to do them, put in order the systems to evaluate the health of the participants, and a very long etc.
If they put their name and careers behind their recommendations and say the vaccines candidates or drugs they are developing and testing are safer than the disease they are preventing or treating definitely they are much more trustworthy than a nameless person of the internet that does not even have an idea about how the whole process is done and think "pharma" is some kind of all powerful entity that does everything by itself.
Peter Neil
Where did some of you come up with testing a vaccine from this article?